Caribou Biosciences Announces CFO Resignation and Succession Plan
PremiumCompany AnnouncementsCaribou Biosciences Announces CFO Resignation and Succession Plan
2M ago
Caribou Biosciences CFO Jason O’Byrne resigns
Premium
The Fly
Caribou Biosciences CFO Jason O’Byrne resigns
2M ago
Caribou Biosciences says FDA grants Fast Track designations to CB-010
Premium
The Fly
Caribou Biosciences says FDA grants Fast Track designations to CB-010
2M ago
Caribou Biosciences Updates on CAR-T Therapy Trial and ASCO Presentation
PremiumCompany AnnouncementsCaribou Biosciences Updates on CAR-T Therapy Trial and ASCO Presentation
5M ago
Caribou Biosciences downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Caribou Biosciences downgraded to In Line from Outperform at Evercore ISI
5M ago
Caribou presents clinical data from CB-010 ANTLER Phase 1 trial
Premium
The Fly
Caribou presents clinical data from CB-010 ANTLER Phase 1 trial
5M ago
Caribou Biosciences price target raised to $24 from $23 at H.C. Wainwright
PremiumThe FlyCaribou Biosciences price target raised to $24 from $23 at H.C. Wainwright
8M ago
CRBU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRBU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point
Premium
Market News
Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100